113
Participants
Start Date
December 29, 2014
Primary Completion Date
August 25, 2023
Study Completion Date
December 29, 2028
acalabrutinib
rituximab (IV)
Lenalidomide
Research Site, New York
Research Site, Hawthorne
Research Site, Lake Success
Research Site, Syracuse
Research Site, Milan
Research Site, Greenville
Research Site, Coral Gables FL
Research Site, Bologna
Research Site, Louisville
Research Site, Columbus
Research Site, Ann Arbor
Research Site, Waukesha
Research Site, Chicago
Research Site, Chicago
Research Site, Chicago
Research Site, New Orleans
Research Site, Dallas
Research Site, Temple
Research Site, Houston
Research Site, San Antonio
Research Site, Salt Lake City
Research Site, Tucson
Research Site, Palermo
Research Site, Downey
Research Site, Santa Monica
Research Site, Duarte
Research Site, Fountain Valley
Research Site, Spokane
Research Site, Morristown
Research Site, Edmonton
Research Site, London
Research Site, Toronto
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
Acerta Pharma BV
INDUSTRY